3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Breast
1
Conditions
Lung Neoplasms
3
Colorectal Neoplasms
3
Lymphoma
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Quality of Life
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Paranasal Sinus Neoplasms
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Mouth Neoplasms
1
Mixed Dementias
1
Mesothelioma, Malignant
1
Meningeal Carcinomatosis
1
Maxillary Sinus Neoplasms
1
Lymphoma, Follicular
1
Lewy Body Disease
1
Laryngeal Neoplasms
1
Kidney Neoplasms
1
Hypopharyngeal Neoplasms
1
Hematologic Neoplasms
1
Head and Neck Neoplasms
1
Interventions
Pemetrexed
5
Topotecan
3
Dexamethasone
3
Bevacizumab
3
osimertinib
2
Vitamin B 12
2
Trastuzumab
2
Spinal Puncture
2
Radiotherapy
2
Methotrexate
2
Folic Acid
2
Cytarabine
2
Busulfan
2
trioctyl phosphine oxide
1
trastuzumab deruxtecan
1
tipifarnib
1
merphos
1
mafosfamide
1
immunotoxin LMB-7
1
epothilone B
1
avelumab
1
aflutinib
1
XL647
1
Transplantation, Autologous
1
Temozolomide
1
Rituximab
1
Referral and Consultation
1
Radiotherapy, Intensity-Modulated
1
Nivolumab
1
Mental Status and Dementia Tests
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Meningeal Carcinomatosis
×
Referral and Consultation
×
Clear all
NCT05286684
2026-03-18
Exo-LCR
Centre Oscar Lambret
Phase NA
Completed
7 enrolled